CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,404,000 | -2.2% | 12,418 | -13.4% | 0.00% | – |
| Q1 2017 | $1,436,000 | +4.4% | 14,337 | +12.0% | 0.00% | – |
| Q4 2016 | $1,375,000 | -8.1% | 12,796 | +6.4% | 0.00% | – |
| Q3 2016 | $1,497,000 | +31.4% | 12,028 | +12.4% | 0.00% | – |
| Q2 2016 | $1,139,000 | +78.5% | 10,704 | +92.0% | 0.00% | – |
| Q1 2016 | $638,000 | -28.1% | 5,575 | -10.5% | 0.00% | – |
| Q4 2015 | $887,000 | – | 6,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |